Download PDF
Semin intervent Radiol 2016; 33(03): 196-205
DOI: 10.1055/s-0036-1586151
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

MRI-Guided Prostate Biopsy of Native and Recurrent Prostate Cancer

David A. Woodrum
1   Department of Radiology, Mayo Clinic, Rochester, Minnesota
,
Krzysztof R. Gorny
1   Department of Radiology, Mayo Clinic, Rochester, Minnesota
,
Bernadette Greenwood
2   Desert Medical Imaging, Indian Wells, California
,
Lance A. Mynderse
3   Department of Urology, Mayo Clinic, Rochester, Minnesota
› Author Affiliations
Further Information

Publication History

Publication Date:
30 August 2016 (online)

Also available at
    Permissions and Reprints

Abstract

Prostate cancer is the most commonly diagnosed noncutaneous cancer and second-leading cause of death in men. Many patients with clinically organ-confined prostate cancer undergo definitive, curative treatment of the whole gland with either radical prostatectomy or radiation therapy. However, many men are reluctant to take the definitive step due to potential morbidity associated with either therapy. A growing interest in active surveillance or focal therapy has emerged as realistic alternatives for many patients. With each of these management strategies, it is critical to accurately quantify and stage the cancer with improved biopsy targeting and more precise imaging with magnetic resonance imaging (MRI). Furthermore, having dependable prostate imaging allows for targeted biopsies to improve the yield of clinically significant prostate cancer and decrease detection of indolent prostate cancer. MRI-guided targeted biopsy techniques include cognitive MRI/transrectal ultrasound fusion biopsy, in-bore transrectal targeted biopsy using a calibrated guidance device, and in-bore direct MR-guided transperineal biopsy with a software-based transperineal grid template. Herein we present a contemporary review of MRI-guided targeted biopsy techniques for new and recurrent cancerous foci of the prostate.

Keywords

needle biopsy - MRI - MRI targeted biopsy - prostate cancer - interventional radiology
 

  • References

  • 1 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66 (1) 7-30
    CrossrefPubMedGoogle Scholar
  • 2 Vickers AJ, Ulmert D, Sjoberg DD , et al. Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study. BMJ 2013; 346: f2023
    CrossrefPubMedGoogle Scholar
  • 3 Bill-Axelson A, Holmberg L, Garmo H , et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med 2014; 370 (10) 932-942
    CrossrefPubMedGoogle Scholar
  • 4 Cooner WH, Mosley BR, Rutherford Jr CL , et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. 1990. J Urol 2002; 167 (2, Pt 2) 966-973 , discussion 973–975
    CrossrefPubMedGoogle Scholar
  • 5 Flanigan RC, Catalona WJ, Richie JP , et al. Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer. J Urol 1994; 152 (5, Pt 1) 1506-1509
    PubMedGoogle Scholar
  • 6 Maxeiner A, Stephan C, Durmus T, Slowinski T, Cash H, Fischer T. Added value of multiparametric ultrasonography in magnetic resonance imaging and ultrasonography fusion-guided biopsy of the prostate in patients with suspicion for prostate cancer. Urology 2015; 86 (1) 108-114
    CrossrefPubMedGoogle Scholar
  • 7 Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989; 142 (1) 71-74 , discussion 74–75
    PubMedGoogle Scholar
  • 8 Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 2006; 175 (5) 1605-1612
    CrossrefPubMedGoogle Scholar
  • 9 Jones JS. Saturation biopsy for detecting and characterizing prostate cancer. BJU Int 2007; 99 (6) 1340-1344
    CrossrefPubMedGoogle Scholar
  • 10 Lane BR, Zippe CD, Abouassaly R, Schoenfield L, Magi-Galluzzi C, Jones JS. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy. J Urol 2008; 179 (5) 1746-1750 , discussion 1750
    CrossrefPubMedGoogle Scholar
  • 11 Nelson AW, Harvey RC, Parker RA, Kastner C, Doble A, Gnanapragasam VJ. Repeat prostate biopsy strategies after initial negative biopsy: meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy. PLoS ONE 2013; 8 (2) e57480
    CrossrefPubMedGoogle Scholar
  • 12 Ahmed HU, Emberton M, Kepner G, Kepner J. A biomedical engineering approach to mitigate the errors of prostate biopsy. Nat Rev Urol 2012; 9 (4) 227-231
    CrossrefPubMedGoogle Scholar
  • 13 Salami SS, Ben-Levi E, Yaskiv O , et al. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?. BJU Int 2015; 115 (4) 562-570
    CrossrefPubMedGoogle Scholar
  • 14 Arumainayagam N, Ahmed HU, Moore CM , et al. Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard. Radiology 2013; 268 (3) 761-769
    CrossrefPubMedGoogle Scholar
  • 15 Ahmed HU, Kirkham A, Arya M , et al. Is it time to consider a role for MRI before prostate biopsy?. Nat Rev Clin Oncol 2009; 6 (4) 197-206
    CrossrefPubMedGoogle Scholar
  • 16 Moore CM, Robertson NL, Arsanious N , et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 2013; 63 (1) 125-140
    CrossrefPubMedGoogle Scholar
  • 17 Penzkofer T, Tuncali K, Fedorov A , et al. Transperineal in-bore 3-T MR imaging-guided prostate biopsy: a prospective clinical observational study. Radiology 2015; 274 (1) 170-180
    CrossrefPubMedGoogle Scholar
  • 18 Hamoen EH, de Rooij M, Witjes JA, Barentsz JO, Rovers MM. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for prostate cancer detection with multiparametric magnetic resonance imaging: a diagnostic meta-analysis. Eur Urol 2015; 67 (6) 1112-1121
    CrossrefPubMedGoogle Scholar
  • 19 Fütterer JJ, Briganti A, De Visschere P , et al. Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol 2015; 68 (6) 1045-1053
    CrossrefPubMedGoogle Scholar
  • 20 Schoots IG, Petrides N, Giganti F , et al. Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review. Eur Urol 2015; 67 (4) 627-636
    CrossrefPubMedGoogle Scholar
  • 21 Turkbey B, Mani H, Shah V , et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol 2011; 186 (5) 1818-1824
    CrossrefPubMedGoogle Scholar
  • 22 Muller BG, Shih JH, Sankineni S , et al. Prostate cancer: interobserver agreement and accuracy with the revised prostate imaging reporting and data system at multiparametric MR imaging. Radiology 2015; 277 (3) 741-750
    CrossrefPubMedGoogle Scholar
  • 23 Siddiqui MM, Rais-Bahrami S, Turkbey B , et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 2015; 313 (4) 390-397
    CrossrefPubMedGoogle Scholar
  • 24 Kitajima K, Murphy RC, Nathan MA , et al. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil. J Nucl Med 2014; 55 (2) 223-232
    CrossrefPubMedGoogle Scholar
  • 25 Muller BG, Fütterer JJ, Gupta RT , et al. The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel. BJU Int 2014; 113 (2) 218-227
    CrossrefPubMedGoogle Scholar
  • 26 Reske SN, Blumstein NM, Glatting G. [11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy. Eur J Nucl Med Mol Imaging 2008; 35 (1) 9-17
    CrossrefPubMedGoogle Scholar
  • 27 Piert M, Montgomery J, Kunju LP , et al. 18F-choline PET/MRI: the additional value of PET for MRI-guided transrectal prostate biopsies. J Nucl Med 2016;
    PubMedGoogle Scholar
  • 28 Haffner J, Lemaitre L, Puech P , et al. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJU Int 2011; 108 (8, Pt 2) E171-E178
    CrossrefPubMedGoogle Scholar
  • 29 Valerio M, McCartan N, Freeman A, Punwani S, Emberton M, Ahmed HU. Visually directed vs. software-based targeted biopsy compared to transperineal template mapping biopsy in the detection of clinically significant prostate cancer. Urol Oncol 2015; 33 (10) 424.e9-424.e16
    CrossrefPubMedGoogle Scholar
  • 30 Linder BJ, Kawashima A, Woodrum DA , et al. Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging. Can J Urol 2014; 21 (3) 7283-7289
    PubMedGoogle Scholar
  • 31 Meng X, Rosenkrantz AB, Mendhiratta N , et al. Relationship between prebiopsy multiparametric magnetic resonance imaging (MRI), biopsy indication, and MRI-ultrasound fusion-targeted prostate biopsy outcomes. Eur Urol 2016; 69 (3) 512-517
    CrossrefPubMedGoogle Scholar
  • 32 Sonn GA, Chang E, Natarajan S , et al. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol 2014; 65 (4) 809-815
    CrossrefPubMedGoogle Scholar
  • 33 Hoeks CM, Schouten MG, Bomers JG , et al. Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers. Eur Urol 2012; 62 (5) 902-909
    CrossrefPubMedGoogle Scholar
  • 34 Garmer M, Busch M, Mateiescu S, Fahlbusch DE, Wagener B, Grönemeyer DH. Accuracy of MRI-targeted in-bore prostate biopsy according to the Gleason score with postprostatectomy histopathologic control—a targeted biopsy-only strategy with limited number of cores. Acad Radiol 2015; 22 (11) 1409-1418
    CrossrefPubMedGoogle Scholar
  • 35 McNichols RJ, Gowda A, Gelnett MD, Stafford RJ. Percutaneous MRI-Guided Laser Thermal Therapy in Canine Prostate. Photonic Therapeutics and Diagnostics. 1 ed. San Jose, CA: SPIE; 2005: 214-25
    Google Scholar
  • 36 Elhawary H, Zivanovic A, Rea M , et al. The feasibility of MR-image guided prostate biopsy using piezoceramic motors inside or near to the magnet isocentre. Med Image Comput Comput Assist Interv 2006; 9 (Pt 1) 519-526
    PubMedGoogle Scholar
  • 37 Lagerburg V, Moerland MA, van Vulpen M, Lagendijk JJ. A new robotic needle insertion method to minimise attendant prostate motion. Radiother Oncol 2006; 80 (1) 73-77
    CrossrefPubMedGoogle Scholar
  • 38 van den Bosch MR, Moman MR, van Vulpen M , et al. MRI-guided robotic system for transperineal prostate interventions: proof of principle. Phys Med Biol 2010; 55 (5) N133-N140
    CrossrefPubMedGoogle Scholar